5—F_u治疗前列腺增生症(BPH),国内极少报告。据 Dorfmam动物实验表明,5—F_u的抗雄活性比黄体酮大10～20倍。我们无选择地应用5—F_u治疗BPH20例,并用乙烯雌酚对比治疗10例。实践证明,5—F_u 治疗 BPH效果好,无明显副作用。现总结如下:一、病例选择5—F_u 组:20例 BPH 患者中,年龄在56～78岁之间,以60～70岁为多,共14例,占70%。病史在半年至5年之间。均有排尿费 5-F_u treatment of benign prostatic hyperplasia (BPH), rarely reported in the country. According to Dorfmam animal experiments show that 5-F_u anti-androgynous activity than progesterone 10 to 20 times. We have no choice of 5-F_u BPH treatment of 20 cases, and compared with diethylstilbestrol treatment of 10 cases. Practice has proved that 5-F_u treatment BPH good effect, no obvious side effects. Are summarized as follows: First, the case selection 5-F_u group: 20 cases of BPH patients, aged 56 to 78 years old, 60 to 70 years old more, a total of 14 cases, accounting for 70%. History of six months to five years. Have urination fee